What companies are EBS's competitors?

Emergent BioSolutions Inc. (EBS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does EBS compare to its peers?

The peer comparison table on this page shows Emergent BioSolutions Inc. (EBS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does EBS operate in?

Emergent BioSolutions Inc. (EBS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

EBS

Emergent BioSolutions Inc.

NYSE·Drug Manufacturers, Specialty & Generic · Healthcare

$6.67$0.33+5.21%

After hours·$6.67+0.00%

Market cap$341.99M·Market closed·Oct 27 4:00 PM EDT

Frequently Asked Questions About EBS

What companies are EBS's competitors?: Emergent BioSolutions Inc. (EBS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does EBS compare to its peers?: The peer comparison table on this page shows Emergent BioSolutions Inc. (EBS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does EBS operate in?: Emergent BioSolutions Inc. (EBS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

EBS

Emergent BioSolutions Inc.

NYSE·Drug Manufacturers, Specialty & Generic · Healthcare

$6.67$0.33+5.21%

After hours·$6.67+0.00%

Market cap$341.99M·Market closed·Oct 27 4:00 PM EDT

Peers

Sort:


CMPSCMPSCOMPASS Pathways plc	COMPASS Pathways plc	$11.05	$1.5B
RIGLRIGLRigel Pharmaceuticals, Inc.	Rigel Pharmaceuticals, Inc.	$50.55	$944.3M
CRVSCRVSCorvus Pharmaceuticals, Inc.	Corvus Pharmaceuticals, Inc.	$10.54	$886.6M
ESPRESPREsperion Therapeutics, Inc.	Esperion Therapeutics, Inc.	$3.18	$661.1M
OLMAOLMAOlema Pharmaceuticals, Inc.	Olema Pharmaceuticals, Inc.	$7.04	$616.0M
AQSTAQSTAquestive Therapeutics, Inc.	Aquestive Therapeutics, Inc.	$4.07	$510.8M
PRTAPRTAProthena Corporation plc	Prothena Corporation plc	$8.81	$452.3M
SNDLSNDLSNDL Inc.	SNDL Inc.	$1.27	$312.6M
SIGASIGASIGA Technologies, Inc.	SIGA Technologies, Inc.	$3.20	$229.9M
ORGOORGOOrganogenesis Holdings Inc.	Organogenesis Holdings Inc.	$0.90	$116.1M

Frequently Asked Questions About EBS

What companies are EBS's competitors?: Emergent BioSolutions Inc. (EBS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does EBS compare to its peers?: The peer comparison table on this page shows Emergent BioSolutions Inc. (EBS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does EBS operate in?: Emergent BioSolutions Inc. (EBS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.